Evidence map›Paper›PMID 39365108›Full record

ArticleMicrobiology spectrum2024

Diversity of culturable bacterial isolates and their potential as antimicrobial against human pathogens from Afar region, Ethiopia.

Sisay Demisie, Dong-Chan Oh, Dawit Wolday, Tobias F Rinke de Wit, Adugna Abera, Geremew Tasew, Abebe Mekuria Shenkutie, Sisay Girma, Ketema Tafess

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cancer Chemopreventive Potential ofMolecules (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sisay DemisieDepartment of Applied Biology, School of Applied Natural Science, Adama Science and Technology University, Adama, Ethiopia.
Dong-Chan OhNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South Korea.
Dawit WoldayDepatment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada.
Tobias F Rinke de WitDepartment of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
Adugna AberaEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Geremew TasewDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.
Abebe Mekuria ShenkutieDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.
Sisay GirmaCollege of Veterinary Medicine and Agriculture, Addis Ababa University, Bishoftu, Ethiopia.
Ketema TafessDepartment of Applied Biology, School of Applied Natural Science, Adama Science and Technology University, Adama, Ethiopia.ORCID 0000-0001-8379-4245

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance is a growing global concern exacerbated by the scarcity of new medications and resistance to current antibiotics. Microbes from unexplored habitats are promising sources of natural products to combat this challenge. This study aimed to isolate bacteria producing secondary metabolites and assess their antimicrobial efficacy against human pathogens. Soil and liquid samples were collected from Afar region, Ethiopia. Bacterial isolates were obtained using standard serial dilution techniques. Antimicrobial activity was evaluated using agar plug and well diffusion methods. matrix-assisted laser desorption/ionization time-of-flight-mass spectrometry (MALDI-TOF MS) and whole-genome sequencing (WGS) were conducted for the isolate exhibiting the highest antimicrobial activity. Secondary metabolites were extracted and analyzed using gas chromatography-mass spectra (GC-MS). In this study, 301 bacteria isolates were identified, of which 68 (22.6%) demonstrated antagonistic activity against at least one reference pathogen. Whole-genome sequencing revealed that Sl00103 belongs to the genus Bacillus, designated as Bacillus sp. Sl00103. The extract of Sl00103 showed zones of inhibition ranging between 17.17 ± 0.43 and 26.2 ± 0.4 mm against bacterial pathogens and 19.5 ± 0.44 to 21.0 ± 1.01 mm against IMPORTANCE: Antimicrobial resistance (AMR) is an escalating global health threat affecting humans, animals, and the environment, underscoring the urgent need for alternative pathogen control methods. Natural products, particularly secondary metabolites from bacteria, continue to be a vital source of antibiotics. However, microbial habitats and metabolites in Africa remain largely unexplored. In this study, we isolated and screened bacteria from Ethiopia's Afar region, characterized by extreme conditions like high temperatures, volcanic activity, high salinity, and hot springs to identify potential bioactive compounds. We discovered diverse bacterial isolates with antimicrobial activity against various pathogens, including strain Sl00103 (Bacillus sp. Sl00103), which demonstrated significant antimicrobial and antioxidant activities. GC-MS analysis identified several antimicrobial compounds, highlighting strain Sl00103 as a promising source of secondary metabolites with potential pharmaceutical applications and warranting further investigation.

Indexed as

Anti-Bacterial AgentsBacteriaMicrobial Sensitivity TestsBacillusCandida albicansEthiopiaHumansSoil MicrobiologyWhole Genome SequencingAnti-Bacterial Agentsantimicrobial activityGC–MSMALDI-TOF MSsecondary metabolitesWGS

Identifiers

PMID39365108
PMCPMC11537106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.